Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Focal segmental glomerulosclerosis].

K Matousovic1, P Rossmann, V Prát

  • 1Institut klinické a experimentální medicíny, Praha.

Vnitrni Lekarstvi
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of stigma related to visible skin diseases: a systematic review and evaluation of patient-reported outcome measures.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice.

Physiological research·2017
Same author

[Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis)].

Vnitrni lekarstvi·2013
Same author

[End stage of chronic kidney disease and metabolic acidosis].

Vnitrni lekarstvi·2012
Same author

[To salt or not to salt in kidney diseases? Not more than quantum satis!].

Vnitrni lekarstvi·2012
Same author

[Precariousness, DRG's and health planning: pilot study at the Lariboisière hospital in Paris].

Gynecologie, obstetrique & fertilite·2011
Same journal

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023
Same journal

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023
Same journal

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023
Same journal

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023
Same journal

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023
Same journal

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023
See all related articles

Focal and segmental glomerulosclerosis (FSGS) is a kidney disease causing high proteinuria. Remission rates are low, with many patients experiencing renal failure within ten years.

Area of Science:

  • Nephrology
  • Pathology

Context:

  • Focal and segmental glomerulosclerosis (FSGS) represents 4.1% of primary glomerulopathies.
  • FSGS is characterized by arteriolosclerosis, high proteinuria, mild hematuria, and frequent nephrotic syndrome.

Purpose:

  • To investigate the clinical course and outcomes of patients with focal and segmental glomerulosclerosis.

Summary:

  • The study found a 10-year remission rate of 30% for FSGS, with remission linked to normal serum creatinine and minimal tubulointerstitial changes at biopsy.
  • Renal failure occurred in 40% of patients within 10 years.
  • Factors like nephrotic syndrome, extracapillary proliferation, and advanced tubulointerstitial changes were associated with poorer kidney survival.

Impact:

Related Experiment Videos

  • Identifies key prognostic factors for FSGS, aiding in risk stratification and patient management.
  • Highlights the significant risk of renal failure in FSGS patients, underscoring the need for early detection and intervention.